HACKENSACK, N.J., January 17th, 2017 – With 27 existing cancer care delivery locations throughout New Jersey, Maryland and Washington, D.C., Regional Cancer Care Associates, or RCCA, started 2017 by adding six Connecticut-based cancer specialists to the network. RCCA’s northward expansion to Connecticut is keeping in line with the network’s mission to give patients access to comprehensive, patient-centric treatment in their own communities.
This new Connecticut-based division of RCCA has practice locations in both Hartford and Manchester, and the cancer specialists’ hospital affiliations include Saint Francis Hospital and Medical Center in Hartford, Manchester Memorial Hospital in Manchester and Rockville General Hospital in Vernon, CT. The six cancer specialists who are joining RCCA in the Connecticut locations are Charanjeev S. Kapoor, MD; Joseph F. McLaughlin, MD; Mohammad Pazooki, MD; Michael A. Reale, MD, PhD; Joel S. Silver, MD; and Joseph G. Sinning, MD.
Terrill Jordan, President and CEO of RCCA, said, “We are honored that some of the most highly regarded oncologists and hematologists practicing in Connecticut have chosen to join RCCA due to our shared commitment to community-based care, maintaining an unwavering focus on the patient, and the primacy of the physician in clinical decision-making.” Mr. Jordan added, “In an increasingly complex healthcare environment marked by both unparalleled opportunities to help cancer patients and unprecedented operational and financial challenges for physicians, RCCA exists to help both patient and physician thrive.”
Chairperson of the Board of RCCA and practicing medical oncologist, Edward J. Licitra, said, “In October 2015, RCCA expanded from its New Jersey base to Maryland and Washington, DC, marking one of the first instances of a fully unified cancer care organization expanding across state lines. We are proud and excited to be following that successful endeavor with the establishment of this new division in Connecticut. RCCA long has been recognized for providing innovative care, including by the Centers for Medicare and Medicaid Services’ recent selection of our network to participate in its Oncology Care Model, a new payment and care-delivery model designed to improve the effectiveness and efficiency of specialty care for patients undergoing chemotherapy. We look forward to working with our Connecticut-based colleagues to further extend that record of outstanding patient care delivered in the community setting.”
One of the Connecticut-based cancer specialists joining RCCA, Michael A. Reale, MD, PhD, said, “At a time when the evolution of healthcare delivery in the US necessitates that physicians affiliate with larger entities, it was important to me to join a physician-owned and –operated network that reflected my own philosophy of providing comprehensive, compassionate, and personalized care in a setting that supports a strong physician-patient relationship.” Dr. Reale went on to say, “Additionally, my colleagues and I are involved in a number of clinical research projects, and RCCA’s extensive clinical trials program will enable us to continue that vital work and to offer our patients access to a variety of studies and cutting-edge therapies.”
With more than 100 oncologists, 100 RN’s and 750 staff members, Regional Cancer Care Associates (RCCA) is one of the U.S.’s largest oncology physician networks. RCCA provides high-quality cancer care at each of its 29 locations, granting patients greater access to treatment and specialists who can treat all types of cancer. Offering the latest oncology technologies and therapies, RCCA strives to create compassionate, community-based locations, where cancer patients can receive care close to home. For more information on RCCA, visit http://www.RCCA.com.
For further information, contact:
Mary Lou Salvemini